AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Genuit Group PLC

AGM Information May 23, 2019

4912_dva_2019-05-23_1aa6a452-dd00-4254-863b-ae817799244b.html

AGM Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0281A

Polypipe Group PLC

23 May 2019

POLYPIPE GROUP PLC

(the "Company")

Results of Annual General Meeting

23 May 2019

Polypipe Group plc announces that at the Annual General Meeting ("AGM") of the Company held today, all the Resolutions contained in the Notice of AGM were duly passed on a show of hands. 

The total number of proxy votes received in respect of each such resolution 48 hours prior to the

meeting is set out below.

Resolution In favour % Against % Withheld / Abstained
1. To receive the audited accounts of the Company for the year ended 31 December 2018 and the Directors' Report and the Auditor's Report 162,126,168 99.38 1,011,574 0.62 466,355
2. To approve the Directors' Remuneration Report for the year ended 31 December 2018 163,212,795 99.79 347,249 0.21 44,053
3. To declare a final dividend of 7.9 pence per Ordinary Share for the year ended 31 December 2018 163,600,852 100 0 0 3,246
4. To elect Ms Louise Hardy as a Director of the Company 163,142,035 99.72 458,817 0.28 3,246
5. To re-elect Mr Martin Payne as a Director of the Company 161,250,333 98.56 2,350,519 1.44 3,246
6. To re-elect Mr Paul James as a Director of the Company 162,092,005 99.08 1,508,619 0.92 3,474
7. To re-elect Mr Glen Sabin as a Director of the Company 162,111,390 99.09 1,489,234 0.91 3,474
8. To re-elect Mr Ron Marsh as a Director of the Company 157,606,957 98.21 2,864,560 1.79 3,132,580
9. To re-elect Mr Paul Dean as a Director of the Company 161,101,774 98.47 2,496,198 1.53 6,126
10. To re-elect Mrs Moni Mannings as a Director of the Company 162,464,250 99.31 1,133,950 0.69 5,898
11. To re-elect Mr Mark Hammond as a Director of the Company 161,465,122 98.7 2,132,850 1.3 6,126
12. To reappoint Ernst & Young LLP as auditor of the Company 163,560,416 100 0 0 43,681
13. To authorise the Audit Committee to determine auditor's remuneration 163,600,499 100 0 0 3,599
14. To authorise the Directors to allot shares 158,580,017 96.93 5,020,710 3.07 3,371
15. To authorise the Directors to allot shares for cash and to disapply pre-emption rights 160,409,036 98.05 3,186,191 1.95 8,871
16. To authorise the Directors to allot shares for cash and to disapply pre-emption rights in connection with an acquisition or other capital investment 154,687,931 94.56 8,907,295 5.44 8,871
17. To authorise the Company to make market purchases of its own shares 163,497,610 99.96 63,219 0.04 43,268
18. To authorise the Company to call a general meeting (other than an annual general meeting) on not less than 14 clear days' notice 157,249,104 96.12 6,346,248 3.88 8,746

The total number of shares on the register at close of business on 21 May 2019, being those eligible to be voted on at the AGM, was 199,770,986.

In accordance with Listing Rule 9.6.2 copies of all resolutions passed as Special Resolutions at the AGM will be submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/nsm.

These resolutions will also available on the Polypipe website at http://investors.polypipe.com.

For further enquiries, please contact:

Emma Versluys                                                                                    + 44 (0) 1709 770 000

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

RAGEAASDALENEFF

Talk to a Data Expert

Have a question? We'll get back to you promptly.